BamSEC and AlphaSense Join Forces
Learn More

Genvec Inc

Formerly NASDAQ: GNVC

Material Contracts Filter

EX-10.31
from 10-K 10 pages Third Amendment to Lease Agreement
12/34/56
EX-10.30
from 10-K 8 pages Second Amendment to Lease Agreement
12/34/56
EX-10.29
from 10-K 11 pages First Amendment to Lease Agreement
12/34/56
EX-10.28
from 10-K 39 pages Lease Agreement
12/34/56
EX-10.1
from 8-K 39 pages Securities Purchase Agreement
12/34/56
EX-10.33
from 10-K 4 pages Amendment No. 1 to Research Collaboration and License Agreement
12/34/56
EX-10.10
from 10-K 8 pages Genvec, Inc. 2015 Omnibus Incentive Plan Director Non-Qualified Stock Option Agreement Cover Sheet
12/34/56
EX-10.9
from 10-K 8 pages Genvec, Inc. 2015 Omnibus Incentive Plan Director Non-Qualified Stock Option Agreement Cover Sheet
12/34/56
EX-10.8
from 10-K 9 pages Genvec, Inc. 2015 Omnibus Incentive Plan Incentive Stock Option Agreement Cover Sheet
12/34/56
EX-10.1
from 8-K 38 pages Genvec, Inc. 2015 Omnibus Incentive Plan
12/34/56
EX-10.1
from 8-K 8 pages March 13, 2014 the Undersigned (The “Investor”) Hereby Confirms and Agrees With You as Follows: 1. This Purchase Agreement (The “Agreement”) Is Made as of the Date Hereof Between Genvec, Inc., a Delaware Corporation (The “Company”), and the Investor That Is a Signatory to This Agreement
12/34/56
EX-10.1
from 8-K 1 page Amendment to Genvec, Inc. 2011 Omnibus Incentive Plan
12/34/56
EX-10.3
from 10-Q 30 pages Genvec, Inc. 2011 Omnibus Incentive Plan
12/34/56
EX-10.2
from 10-Q 1 page Genvec, Inc. 2011 Omnibus Incentive Plan
12/34/56
EX-10.1
from 10-Q 4 pages Section Sf 30 Block 14 Continuation Page Summary of Changes Section a - Solicitation/Contract Form the Total Cost of This Contract Was Decreased by $2,099,893.01 From $3,519,999.60 to $1,420,106.59. Section B - Supplies or Services and Prices Clin 0001 the Pricing Detail Quantity Has Decreased by [*]From [*]To [*]. the Total Cost of This Line Item Has Decreased by $183,955.76 From $827,800.92 to $643,845.16. Clin 0002 the Pricing Detail Quantity Has Decreased by [*] From [*]To [*]. the Total Cost of This Line Item Has Decreased by $1,841,670.86 From $2,600,005.92 to $758,335.06. Clin 0003 the Pricing Detail Quantity Has Decreased by [*] From [*]To [*]. the Total Cost of This Line Item Has Decreased by $74,266.39 From $92,192.76 to $17,926.37. Section F - Deliveries or Performance the Following Delivery Schedule Item for Clin 0001 Has Been Changed From
12/34/56
EX-10.2
from 10-Q 5 pages 11, This Item Only Applies to Amendments of Solicitations
12/34/56
EX-10.1
from 10-Q 2 pages 11. This Item Only Applies to Amendments of Solicitations
12/34/56
EX-10.43
from 10-K 3 pages Second Amendment to Research Collaboration and License Agreement
12/34/56
EX-10.25
from 10-K 2 pages Amendment No. 1 to Salary Continuation Agreement
12/34/56
EX-10.24
from 10-K 6 pages Salary Continuation Agreement
12/34/56